Article
Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and meta-analysis of 45 studies.
Oncotarget - 15 Nov 2016
Zhang Meng, Wang Yangyang, Fang Tingting, Cai Yangke, Xu Yue, Yan Cunye, Zhang Li, Liang Chaozhao
Abstract excerpt
CD44 is one of the commonly recognized stem cell markers, which plays a critical role in many cancer related cellular processes. Relationships between CD44 polymorphisms and cancer risk have been widely investigated previously, whereas results derived from these studies were inconclusive and controversial. We conducted present meta-analysis aiming to explore the association between CD44 polymorphisms and cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
